<DOC>
	<DOCNO>NCT02018328</DOCNO>
	<brief_summary>Background Aims - H.pylori common human pathogen almost 50 % world population infect . According accepted guideline , H.pylori infection diagnose , first line therapy three drug give . The triple treatment include proton-pump-inhibitor-clarithromycin-amoxicillin eradication rate 70-80 % . - Curcumin many beneficial merit also demonstrate efficient inhibition H.pylori infection , vitro.Therefore aim investigate whether addition Curcumin standard triple therapy increase eradication rate H.pylori infection . Methods - 150 consecutive patient undergo esophagogastroscopy Gastroenterology department positive H.pylori accord urease test gastric biopsy , include . The patient randomize two different treatment , accord binomial distribution . 75 patient treated standard triple therapy 10 day 75 , treat 10 day , triple therapy combine Curcumin give three time day . - During treatment patient complete adverse effect 's questionnaire . 6 week completion treatment patient undergo urea breath test confirm eradication . Patients ask avoid antibiotic , bismuth compound proton-pump-inhibitor second urea-breath-test . - We compare eradication rate adverse effect two group use SPSS</brief_summary>
	<brief_title>The Impact Addition Curcumin 10 Days Triple Therapy , Eradication Rate Helicobacter Pylori Infection</brief_title>
	<detailed_description />
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>positivity Helicobacter pylorus urease test gastric biopsy prior treatment H. pylorus allergy penicillin gastric outlet obstruction pregnancy breast feed inability understand inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>